Results 261 to 270 of about 345,959 (307)
Some of the next articles are maybe not open access.
Perspectives for Adjuvant Therapy
Surgical Clinics of North America, 1981Future trends in adjuvant therapy appear to be directed toward better selection of patients by more sophisticated and sensitive methods, improved selection and integration of adjuvant modalities, prediction of the toxicity associated with adjuvant therapy, and the introduction of new agents and modalities to treat minimal residual neoplastic disease.
M W, Burk, D L, Morton
openaire +2 more sources
Current Treatment Options in Oncology, 2019
In recent years, the number of patients with malignant melanoma has continued to increase globally; surgery remains the first treatment option for patients with resectable melanoma. Adjuvant therapy for patients with stage III and IV melanoma following surgical resection has gradually been approved. After complete resection, these patients can probably
Maiko, Wada-Ohno +2 more
openaire +2 more sources
In recent years, the number of patients with malignant melanoma has continued to increase globally; surgery remains the first treatment option for patients with resectable melanoma. Adjuvant therapy for patients with stage III and IV melanoma following surgical resection has gradually been approved. After complete resection, these patients can probably
Maiko, Wada-Ohno +2 more
openaire +2 more sources
Neoadjuvant Therapy Versus Adjuvant Therapy
2012This chapter describes an aspect of study design for oncology clinical trials (and in daily oncology clinical practice), namely, the choice of neoadjuvant therapy, which occurs before surgery, and adjuvant therapy, which occurs after therapy. Neoadjuvant therapy and adjuvant therapy each have specific advantages.
openaire +1 more source
Seminars in Cutaneous Medicine and Surgery, 2003
The incidence of melanoma is rapidly increasing, especially in younger female and older male patients. Recent fundamental advances in our knowledge of melanoma tumorigenesis have established roles for inhibitors of the MAPK pathway and regulatory immune checkpoints CTLA-4 and PD-1/PD-L1.
Larisa, Geskin +2 more
openaire +2 more sources
The incidence of melanoma is rapidly increasing, especially in younger female and older male patients. Recent fundamental advances in our knowledge of melanoma tumorigenesis have established roles for inhibitors of the MAPK pathway and regulatory immune checkpoints CTLA-4 and PD-1/PD-L1.
Larisa, Geskin +2 more
openaire +2 more sources
Oncology Research and Treatment, 2003
Despite intensive research and numerous clinical trials on the adjuvant treatment of patients with high-risk cutaneous melanoma, the issue is still controversial. Early positive results from studies on adjuvant chemo- and immunotherapy were based on historical controls and could not be confirmed by prospective randomized trials.
P, Mohr, M, Weichenthal, A, Hauschild
openaire +2 more sources
Despite intensive research and numerous clinical trials on the adjuvant treatment of patients with high-risk cutaneous melanoma, the issue is still controversial. Early positive results from studies on adjuvant chemo- and immunotherapy were based on historical controls and could not be confirmed by prospective randomized trials.
P, Mohr, M, Weichenthal, A, Hauschild
openaire +2 more sources
Esophageal Cancer: Adjuvant Therapy
The Cancer Journal, 2007In the United States, esophageal cancer is an uncommon but aggressive malignancy. Prior research has focused on the incorporation of chemotherapy and radiotherapy in both the pre- and postoperative setting. Both squamous cell and adenocarcinoma histologies have been treated in trials, with adenocarcinoma now the predominant histology seen in the United
Geoffrey Y, Ku, David H, Ilson
openaire +2 more sources
Breast cancer adjuvant therapy
Cancer, 1990Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and II. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen receptor (ER) status, and menopausal status.
openaire +2 more sources
Archives of Dermatology, 1984
The effectiveness of adjuvant therapy of pemphigus was evaluated by comparing the results of studies of pemphigus treated with corticosteroids and adjuvant as opposed to corticosteroids only. There has been a steady and striking improvement in the prognosis of pemphigus during the past three decades.
openaire +2 more sources
The effectiveness of adjuvant therapy of pemphigus was evaluated by comparing the results of studies of pemphigus treated with corticosteroids and adjuvant as opposed to corticosteroids only. There has been a steady and striking improvement in the prognosis of pemphigus during the past three decades.
openaire +2 more sources
ADJUVANT THERAPY WITH ISOCARBOXAZID
American Journal of Psychiatry, 1960In this series of 47 patients with a variety of depressive reactions, isocarboxazid produced a fair to excellent effect in 63.8% overall, and in 26 of the 27 reactive depressives and schizophrenic apathetics. Although it did not eliminate nor reduce the need for ECT, it was a valuable adjunct to ECT and intensive psychotherapy, particularly in reactive
openaire +2 more sources